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Objective: To assess the feasibility of myocardial perfusion analysis in healthy dogs using
dynamic contrast-enhanced cardiac magnetic resonance (DCE-MR) imaging at rest and
during simulated stress with two doses of adenosine.
Animals: Ten healthy beagle dogs.
Procedures: Dogs were anesthetized and positioned in dorsal recumbency in a 3.0
Tesla MR scanner. Electrocardiogram-triggered dynamic T1-weighted ultrafast gradient
echo images of three slices in short-axis orientation of the heart were acquired during
breath holds and the first pass of gadolinium contrast. Image acquisition was performed
after 4min infusion of 140 µg/kg/min and 280 µg/kg/min adenosine and, after a washout
period, without adenosine, respectively. Images were processed by dividing each slice
into 6 radial segments and perfusion analysis was performed from signal intensity-time
data.
Results: No differences in perfusion parameters were found between segments
within any of the slices, but significant differences were found between slices for peak
enhancement, accumulated enhancement, and the maximum upslope. In addition,
significant differences were found within each slice between data at rest and during
adenosine-induced stress for the relative and absolute maximum upslope, relative peak
enhancement, time to peak, and accumulated enhancement although inter-individual
variation was large and no difference was found between the two stress tests for some
parameters.
Conclusion and Clinical Relevance: Results of this study showed that rest and stress
myocardial perfusion can be assessed using DCE-CMR in dogs using the methods
described. Both, adenosine dose and slice appear to affect perfusion parameters in
healthy dogs and individual response to adenosine was variable.
Keywords:myocardial perfusion, adenosine, dog, heart, dynamic contrast-enhancedmagnetic resonance imaging
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INTRODUCTION
Cardiac magnetic resonance (CMR) imaging is a widely used
modality to assess myocardial tissue and perfusion in people and
has been used in a limited number of studies in dogs and cats
(1–5). The most common contrast-enhanced techniques used
are DGE-CMR(3, 6–11) for detecting myocardial fibrosis and
stress/rest DCE-CMR (12–16) for detectingmyocardial ischemia.
Recent studies show that DCE-CMR compares favorably or
superiorly with single photon emission computed tomography
(SPECT) and positron emission tomography (PET) imaging,
has fewer artifacts, superior spatial resolution and is free from
ionizing radiation compared to SPECT and is not limited to sites
with a cyclotron (12, 14, 17, 18).
First-pass DCE-CMR measures contrast enhancement during
the first pass of a gadolinium bolus through the cardiac
chambers and myocardium using fast imaging techniques. To
track the first pass, dynamic image acquisition is performed
at the same point in the cardiac cycle during successive
heart beats, such that cardiac motion is essentially frozen.
The acquisition is thus a motion-free dynamic series of cross-
sectional images in which signal intensity increases and falls
over time as the bolus of contrast passes through myocardial
tissue(19, 20). Resting images are used to visualize regions of
myocardial hypoperfusion, such as a corresponding coronary
artery infarction. Ischemia associated with arterial stenosis is
identified by the presence of myocardial hypoperfusion under
vasodilator stress (21–24). This is most commonly achieved using
adenosine, which induces vasodilation by activating Adenosine
A2 receptors, leading to smooth muscle relaxation (25). As
adenosine induces vasodilation in healthy but not in stenotic
arteries, redistribution of blood toward non-stenotic regions
from areas supplied by a stenotic vessel (“vascular steal”) allows
detection of low signal areas in hypoperfused myocardium
during the first passage of the contrast agent (26). Previous canine
studies have used invasive intracoronary adenosine (10, 15),
but non-invasive studies have not been performed in dogs and
semi-quantitative or quantitative analyses are lacking. Although
coronary artery disease is of minor importance in dogs, DCE-
CMR may be of value in the diagnosis and characterization of
other disorders that may affect myocardial perfusion or result
in secondary infarction, such as cardiomyopathies, myocarditis,
and cardiac and para-cardiac neoplasia (26–29). Limitations
of DCE-CMR for the use in clinical practice are the need
of breath holds during examination, the relative complex
and time consuming examination, possible adverse effects of
pharmacologic stress agents as well as relative high costs
(19).
The aims of the present study were to assess stress and
resting myocardial perfusion using two rates of intravenous
Abbreviations: AE, Accumulated signal enhancement; CMR, Cardiac magnetic
resonance; DCE-CMR, Dynamic contrast-enhanced cardiac magnetic resonance;
FOV, Field of view;Maxup,Maximum upslope; MRI,Magnetic resonance imaging;
PE, Peak enhancement; rAE, Relative accumulated enhancement; rMaxup, Relative
maximum upslope; rPE, Relative peak enhancement; S1, First stress perfusion
examination; S2, Second stress perfusion examination; TT50P Time to 50% peak
enhancement; TTP, Time to peak enhancement.
infusion of adenosine (140 and 280 µg/kg/min) and attain semi-
quantitative DCE-CMR myocardial perfusion data in the short-
axis orientation (basal, mid-ventricle, and apical slices) in healthy
beagle dogs. The hypotheses were that myocardial perfusion is
increased by adenosine infusion using this method and is not
significantly different between the slices or between adenosine
infusion rates.
MATERIALS AND METHODS
Animals
Ten adult research beagle dogs (5 males and 5 females) were
used in the study. Mean ±SD age was 4.6 ± 0.2 years (range, 4.4
to 4.8 years) and mean body weight was 14.1 ± 2.5 kg (range,
10.0 to 17.3 kg). All dogs were considered healthy based on
physical examination and unremarkable results of a complete
blood count and serum biochemistry panel. The study was
approved by the Cantonal Veterinary Office (License number
ZH001/15) in compliance with the Animal Welfare Act of
Switzerland.
Anesthesia
Dogs were sedated with butorphanol1 (0.2 mg/kg, IM) following
a 12-h fast. Anesthesia was induced with propofol2 (4–6
mg/kg, IV) and maintained with sevoflurane3 (oxygen/air: 1/1)
following endotracheal intubation. Dogs were mechanically
ventilated in volume-controlled mode (10–15 ml/kg) with
respiratory rate adjustment to achieve an end-tidal CO2
of 35–42 mmHg (4.66–5.59 kPa). A 22-gauge cannula was
inserted in the left and right cephalic vein for administration
of gadolinium and intravenous crystalloids, and adenosine,
respectively. Lactated Ringer’s solution (5 ml/kg/h) was
administered throughout anesthesia. Anesthesia monitoring
included heart rate, pulse rate, respiratory rate, invasive arterial
blood pressure, oxygen saturation, inspired- and expired
gases and end-tidal CO2. Monitored anesthesia data is part
of a collateral study and is only partially included in this
manuscript.
Imaging Protocol
The DCE-CMR imaging was performed with a 3.0 Tesla
MRI scanner with the integrated digital whole-body coil4. The
dogs were positioned in dorsal recumbency with the head
toward the gantry. Four MRI-safe electrodes5 were attached
on both sides of the chest wall to trigger the MR acquisition
using a wireless vector cardiography unit6. All images were
acquired during an end-expiratory breath hold to minimize
respiration-induced movement of the heart. This was achieved
by turning off the ventilator prior to contrast administration
1Morphasol, Dr. E. Graeub AG, Bern, Switzerland.
2Propofol, Fresenius Kabi AG, Oberdorf, Switzerland.
3Sevorane, AbbVie AG, Baar, Switzerland.
4Philips Ingenia 3.0T with a dStream anterior/posterior body coil, Philips AG,
Zurich, Switzerland.
5Kendall 750 radiolucent tape electrodes, Medtronic (Schweiz) AG,
Münchenbuchsee, Switzerland.
6Invivo Wireless ECG, Invivo Corporation, Orlando, USA.
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and following hyperventilation to reach an end-tidal CO2 of 35
mmHg. Breath hold controlled respiration until signal intensity
of the myocardium, monitored on real time view, decreased.
Mechanical ventilation was resumed following the second pass
of contrast agent in-between each set of imaging studies.
Initial scout images were performed to determine cardiac
geometry. An initial perfusion test scan (without contrast
administration) was performed to assess the FOV and confirm
that sequence parameters yielded an artifact-free representation
of perfusion. Subsequently, intravenous adenosine was
administered at a rate of 140 µg/kg/min for the first stress
perfusion measurements (S1). Image acquisition and contrast
injection began after 4min of adenosine infusion using 0.05
mmol/kg gadolinium contrast agent7 administered at a rate of
5.0 ml/s, followed by a 12ml saline flush at the same rate, with
a programmable syringe pump8. The second stress perfusion
measurements (S2) were performed in the same way using
intravenous adenosine at a rate of 280 µg/kg/min. A break
of at least 5min between S1 and S2 ensured independent
measurements and limited the risk of carried over effects
caused by late adenosine effects. The protocol prevented
pharmacokinetic interactions between these examinations
because adenosine has a very short biological half-life time
(<10 s in human plasma). Finally, the adenosine infusion was
stopped and rest perfusion images were taken after at least
10-min washout period (Figure 1).
Dynamic T1-weighted ultrafast gradient echo (Turbo field
echo) images were acquired in the short-axis orientation with
one image per cardiac cycle in three left ventricular slices (base,
mid-ventricle, and apical). Imaging was performed during breath
hold with ECG-triggered pulse sequences using the following
pulse sequence parameters: echo time, 1.7ms; repetition time,
3.7ms; number of signal averages, 1; flip angle, 20◦; saturation
prepulse delay, 100ms; echo train length, 31 [equals phase
encoding steps (SSH)]; slice thickness, 10mm; SENSE: yes; FOV,
200 × 200mm; matrix, 92 × 92; voxel size, 2.20 × 2.17mm;
reconstruction voxel size, 1.79mm; reconstruction matrix, 112
(Figure 2). An example of DCE-CMR of a healthy canine heart
is available as Supplementary Video.
Image Processing and Analysis
Images were exported to a dedicated workstation9, which was
used to assess the DICOM images using cardiac imaging analysis
software10. Contours of the left ventricular epicardial and
endocardial borders were drawn by the software and adapted
manually to ensure myocardial enhancement in the stack of
short-axis slices. Each slice was divided into 6 equidistant
radial segments, arranged counter-clockwise starting from the
anterior septal insertion of the right ventricle (Figure 3).
Perfusion data analysis was performed by the software based
on signal intensity-time data, whereby signal intensities from
each of the six segments are plotted for each time point
7Omniscan, GE Healthcare AG, Glattbrugg, Switzerland.
8Accutron MR, Medtron AG, Saarbrücken, Germany.
9Extended MRWorkspace, Philips AG, Zurich, Switzerland.
10Cardiac Explorer, Philips AG, Zurich, Switzerland.
FIGURE 1 | Flow chart depicting the imaging protocol used for DCE-CMR
during stress and rest examination.
to generate dynamic uptake curves (Figure 4). The signal
intensity-time data was analyzed with focus on parameters
during the first pass of contrast medium. During distribution
of contrast medium in the circulation, effects of contrast
medium diffusion into myocardial interstitium influence the
curve (26). The parameters are chosen to characterize the
course of the intensity-time curve and to translate into
numeric values. The analysis included the following parameters:
peak enhancement (PE): maximum signal intensity of the
myocardium normalized by the baseline signal before arrival
of contrast; relative peak enhancement (rPE): maximum signal
intensity relative to that measured in the left ventricle; maximum
upslope (Maxup): maximum increase in signal intensity of
the myocardium determined by linear fit; relative maximum
upslope (rMaxup): maximum increase in signal intensity relative
to that measured in the left ventricle; time to 50% peak
(TT50P): time from contrast arrival in the left ventricle until
50% of the maximum signal intensity of the myocardium was
reached; time to peak (TTP): time from contrast arrival in
the left ventricle to maximum signal intensity; accumulated
enhancement (AE): accumulated signal intensity, calculated
as the area under the intensity-time curve from the start
of increased signal intensity in the myocardium to the
maximum signal intensity; relative accumulated enhancement
(rAE): accumulated signal intensity relative to that in the left
ventricle.
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FIGURE 2 | DCE-CMR of a healthy canine heart using a 3.0 Tesla MRI (Star:
Myocardium, Cross: left ventricle, circle: right ventricle). Short axis view of a
T1-weighted ultrafast gradient echo (Turbo field echo) images at mid ventricle
level during contrast distribution. Images (A–D) aquired at rest perfusion, (E)
and (F) at stress 1 respective stress 2 perfusion. (A) Early time point before
contrast arrival, (B) contrast peak in the right ventricle, left ventricle,
myocadium remain unenhanced, (C) contrast peak in the left ventricle, right
ventricle post peak enhancement, myocadium remain unenhanced, (D)
contrast peak in the myocardium, both ventricles post peak enhancement, (E)
comparable time phase as (D) showing stress 1 perfusion, (F) comparable
time phase as (E) showing stress 2 perfusion.
Statistics
Statistical analysis was performed using a commercial
software package11. Descriptive analyses were performed
for all continuous variables. A two-way ANOVA was used to
analyze the effect of segment and slice on each parameter for
resting perfusion data. A Friedman test was used to analyze
differences between rest, S1 and S2 pulse rates, blood pressures
and perfusion data for each parameter in each slice. Where a
significant difference between rest, S1 and S2 data was found, a
post-hoc Conover analysis based on the mean rank differences
of groups was performed. Significance was set at P < 0.05
throughout.
11IBM SPSS Statistics for Windows, version 21.0, IBM Corp. Armonk, NY, USA.
FIGURE 3 | DCE-CMR image in a healthy beagle dog during adenosine
infusion in the basal short-axis slice, showing the epicardial (yellow line) and
endocardial (green line) contour of the left ventricle and the left ventricular
myocardial segments generated by the analysis software (numbers 1–6).
RESULTS
No complications were observed during anesthesia and all dogs
recovered uneventfully. In two dogs, the R-R interval was reduced
due to high heart rates and a reduced FOV was used for DCE-
CMR image acquisition. No other changes were made to the
sequence parameters.
The mean ±SD pulse rate was 109 ± 12, 119 ± 9, and
123 ± 14 beats/min at rest, S1 and S2, respectively. Rest pulse
rates were significantly lower than S1 and S2 pulse rate but no
difference was found between S1 and S2 pulse rates. The mean
±SD systolic blood pressures were 117 ± 19, 120 ± 24, and 111
± 22 mmHg at rest, S1 and S2, respectively. The systolic pressure
at S2 was significantly lower than at S1 but no difference was
found between rest and either S1 or S2. The mean ±SD diastolic
blood pressures were 65 ± 12, 59 ± 14, and 52 ± 12 mmHg at
rest, S1 and S2, respectively. The diastolic blood pressure at S2
was significantly lower than at rest or at S1 but no difference was
found between rest and S1. The mean ±SD mean arterial blood
pressures were 78 ± 13, 73 ± 15, and 66 ± 13 mmHg at rest,
S1 and S2, respectively. The mean arterial blood pressure at S2
was significantly lower than at rest or at S1 but no difference was
found between rest and S1.
Rest perfusion data revealed no differences between segments
for any of the perfusion parameters but significant differences
were found between slices for Maxup, rMaxup, AE, rAE, PE, and
rPE (Table 1).
Perfusion datasets at rest, S1 and S2 revealed considerable
intra-individual variation and overlap of some data (Table 2).
Significant differences were found between rest and stress
datasets for Maxup, rMaxup, AE, and rPE, TTP and TT50P in all
three slices, and for PE and rAE in at least one slice (Table 2). In
addition, significant differences between S1 and S2 datasets were
found for rPE, TTP and TT50P in all three slices, and for Maxup,
rMaxup, PE, and rAE in at least one slice (Table 2).
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FIGURE 4 | Signal intensity-time curve (x-axis: time in seconds, y-axis: signal intensity) of DCE-CMR, showing signal intensity in the blood pool (red line) of the left
ventricle and the myocardium (black line). Red line: first peak reflects first pass of contrast medium, second peak reflects second pass of contrast medium.
Abbreviations according to the manuscript: PE, TTP, TT50P, Maxup, r Maxup, AE, rAE. Additional abbreviations: maximum upslope of the left ventricle (MaxupLV):
maximum increase in signal intensity determined by linear fit in the left ventricle; accumulated enhancement of the left ventricle (AELV): accumulated signal intensity of
the left ventricle. The chosen parameters characterize the course of the curve and quantify the perfusion data.
TABLE 1 | Perfusion dataset between slices.
Variable Slice P
Basal Mid-ventricular Apical
Maxup (S/s) 213 ± 57* 181 ± 50† 128 ± 38
‡
< 0.001
rMaxup (%) 17.7 ± 4.9* 11.2 ± 3.3† 7.6 ± 2.0
‡
< 0.001
AE (S) 9253 ± 2026* 8220 ± 1818† 5843 ± 1500
‡
< 0.001
rAE (%) 69.5 ± 13.8* 48.7 ± 10.1† 36.7 ± 8.4
‡
< 0.001
PE (S) 1074 ± 186* 931 ± 152† 675 ± 128
‡
< 0.001
rPE (%) 36.2 ± 7.0* 23.3 ± 3.7† 16.0 ± 2.4
‡
< 0.001
TT50P (s) 15.4 ± 2.3 15.6 ± 2.4 15.9 ± 2.5 0.571
TTP (s) 20.9 ± 3.6 21.2 ± 3.7 21.3 ± 3.7 0.793
Data shown as mean ± SD.
*,† ,‡ Values for slices with different superscripts differ significantly (P < 0.05) from each
other.
The absence of superscripts indicates that values did not differ significantly between the
slices for that variable.
DISCUSSION
This study evaluated myocardial perfusion using DCE-CMR at
rest and stress with two different adenosine infusion rates in
healthy beagles. A variety of different methods have been used to
divide the left ventricle into segments in the short-axis view for
DCE-CMR in people, with numbers of segments ranging from 9
to 400, depending on the clinical or research application (30–32).
The American Heart Association Writing Group recommend
6 segments in the basal and mid-ventricle slices but only 5 in
the apical (33). In the present study, 6 segments were selected
in all three slices such that the border between segments was
continuous from the base to the apex of the heart. As no
difference was found in perfusion parameters between segments
within the same slice, the number andmanner in which segments
were chosen does not appear to affect perfusion parameters in
healthy dogs. Moreover, as all other data analyses were based on
the median values in all 6 segments within a slice, variations due
to segment number or position were not evaluated in the present
study. In DCE-CMR in people, standardization of segmentation
is based on assigning individual segments to specific coronary
artery territories although considerable individual variation
exists (33, 34). The extent to which the DCE-CMR segments used
in the present study correlate to specific arterial supply in dogs
was not evaluated in the present study.
The standard three slices (basal, mid-ventricle, and apical) for
the short-axis orientation used in human DCE-CMR were used
in the present study (33). Likewise, a slice thickness of 10mm
used in the present study conforms to that recommended for
imaging in people (33), and adequate images were obtained with
this thickness.
One of the most important challenges of DCE-CMR
are artifacts due to cardiac and respiratory motion (35).
However, electrocardiographic gating and breath holding largely
eliminate these problems. In addition, the need for general
anesthesia in veterinary medicine eliminates the risk of patient
motion but introduces a higher patient risk and possible
alterations in cardiovascular parameters due to sedative and
anesthetic agents (36, 37). This may be a serious limitation
to the clinical use of DCE-CMR in dogs affected by heart
disease.
The goal of simulating stress using adenosine infusion
in DCE-CMR is to create maximum vasodilation of the
coronary arteries. Potential adverse effects of adenosine infusions
in people include bronchospasm, and transient hypotension,
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TABLE 2 | Perfusion dataset at rest, stress 1 and stress 2 examination.
Variable Slice Sequence P
R S1 S2
Maxup (S/s) 1 208 (193–242)* 284 (193–386)† 357 (192–503)‡ < 0.001
2 176 (153–214)* 248 (179–336)† 315 (148–438)‡ < 0.001
3 124 (107–159)* 174 (108–230)† 224 (119–339)‡ < 0.001
rMaxup (%) 1 17.4 (14.1–21.7)* 20.4 (11.0–24.3)† 31.9 (15.5–72.4)‡ < 0.001
2 10.4 (8.8–12.9)* 11.7 (7.6–23.5) 15.3 (7.8–21.9)‡ 0.007
3 7.3 (6.1–8.5)* 10.3 (5.3–14.4)† 12.3 (6.9–18.7)‡ < 0.001
AE (S) 1 9209 (7350–10828)* 8048 (5583–10808)† 8440 (4385–10407)‡ < 0.001
2 8042 (6652–9508)* 7269 (5109–9973)† 6466 (4267–9121)‡ < 0.001
3 5825 (4608–6778)* 4874 (3712–6646)† 5437 (3773–6653)‡ 0.003
rAE (%) 1 70.2 (63.2–78.0) 55.6 (41.6–83.7) 61.4 (51.9–121.7) 0.445
2 46.3 (41.8–55.1)* 40.2 (36.1–48.7)† 38.5 (29.5–52.8)‡ < 0.001
3 35.7 (31.5–41.5) 32.9 (26.9–42.6) 33.9 (26.6–44.3) 0.732
PE (S) 1 1061 (981–1203) 1184 (754–1447) 1146 (974–1383) 0.289
2 920 (840–1034)* 978 (700–1287)† 1032 (862–1254)‡ < 0.001
3 644 (592–786)* 669 (502–910)† 731 (615–1009)‡ < 0.001
rPE (%) 1 36.3 (30.6–41.7)* 31.5 (22.2–38.6)† 43.7 (35.0–83.3)‡ < 0.001
2 23.1 (20.5–25.6)* 22.0 (17.5–26.3)† 26.4 (21.2–32.6)‡ < 0.001
3 15.9 (14.3–17.8)* 17.0 (12.9–21.9)† 19.5 (15.1–22.9)‡ < 0.001
TTP (s) 1 19.7 (18.5–21.7)* 16.9 (15.7–21.0)† 17.3 (13.6–21.6)‡ < 0.001
2 20.4 (18.5–22.5)* 18.3 (16.0–21.5)† 17.3 (13.8–21.3)‡ < 0.001
3 20.2 (18.9–22.4)* 19.1 (16.2–21.0)† 18.7 (13.8–22.2)‡ < 0.001
TT50P (s) 1 15.0 (13.6–16.6)* 14.1 (12.5–15.3)† 13.1 (10.9–15.6)‡ < 0.001
2 15.0 (13.9–16.8)* 14.1 (12.5–15.6)† 13.5 (10.9–16.0)‡ < 0.001
3 15.3 (13.9–16.8)* 14.5 (12.8–15.6)† 13.5 (10.9–15.6)‡ < 0.001
Slice: 1, basal; 2, midventricular; 3, apical.
*,† ,‡ Values within a variable and slice with different superscripts differ significantly (P < 0.05) from each other.
The absence of superscripts indicates that values did not differ significantly between the sequences for that variable and slice.
heart block or sinus tachycardia, and contraindications for
its use include 2nd or 3rd degree atrioventricular block,
hypotension, bradycardia, and active bronchoconstrictive disease
(27). Nonetheless, numerous studies demonstrate that adenosine
infusions can be safely administered (10, 15, 38, 39). The
most frequently recommended dose in people is 140 µg/kg/min
although an increase of up to 210 µg/kg/min has been
recommended if heart rate does not increase and/or blood
pressure does not decrease after 2–3min of the standard rate
of infusion (27). We therefore evaluated both 140 µg/kg/min
and a higher dose of 280 µg/kg/min in order to ensure
maximum stress simulation. As expected, both doses of
adenosine lead to an increase in pulse rate compared to resting
measurements. Although a decrease in blood pressure is observed
in most people following adenosine infusion, this has not
been consistently observed in all people and was contradictory
described in previous studies in dogs (15, 21, 40, 41). The
maximum activity of adenosine in dogs is described to be
about 15–30 s after the injection causing a dose-dependent
sinus bradycardia and a dose-dependent decreasing systemic
pressure as well as an arterial and coronary vasodilation
(42–44).
In the present study, only the higher dose of adenosine
lead to a significant decrease in diastolic and mean arterial
pressure, but no consistent decrease in systolic blood pressure
was found and apparent inter-individual differences in the
sensitivity to adenosine infusion were evident. Based on our
results it is an unsolved question, why the effect of adenosine
was not that reliable as described elsewhere. An explanation
might be, that inter-individual differences of the dogs have had
an influence. Beside different heart rates at rest, gender could
have caused a significant interaction between gender and systolic
blood pressure (45, 46). Although changes in peripheral arterial
blood pressure do not correlate with coronary arterial perfusion,
this finding appears to refute our hypothesis that there is no
difference between adenosine doses. Moreover, rPE was found
to be significantly greater using the higher dose, suggesting
increased myocardial hyperemia at this dose.
The expected effects of adenosine-induced vasodilatation were
a faster TTP, a steeper Maxup and a greater PE compared to
resting perfusion. Although results of the present study were
not statistically significant in all slices for all parameters, Maxup
and PEwere notably different, suggesting that adenosine-induced
myocardial hyperemia can be induced in dogs using the method
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described in this study. Given the apparent inter-individual
variation in blood pressures and perfusion data, further studies
with a bigger population may be necessary to refine the method
and evaluate the extent to which higher adenosine doses (280
µg/kg/min) could be used. Furthermore, clinical relevance has
to be defined regarding the limitations mentioned.
The hypothesis that the choice of slice would have no influence
on myocardial perfusion measurements must be rejected based
on findings in this study. These suggest that signal intensity
decreases from the base to the apex of the heart. This may be due
to physiologic variations in coronary artery blood supply. As the
arteries have their origin at the heart base, more time is necessary
to overcome the distance to the apex of the heart, at which time
signal intensity is lower. The difference in perfusion parameters
between the slices implies that data from a region of interest must
always be compared with data from the same slice.
Given different imaging techniques and methods, direct
comparison of results of this study with previous studies is
difficult. This is the first non-invasive study in dogs describing the
feasibility of myocardial perfusion analysis in healthy dogs using
DCE-MR imaging at rest and during simulated stress with two
different doses of adenosine. Invasive intracoronary adenosine
was already used in previous canine studies (10, 15). Studies with
human patients focused more on the effect of coronary artery
disease (1, 2), the assessment of diastolic function by CMR (28)
or myocardial perfusion and myocardial perfusion reserve index
(14, 26, 47–49).
A clear limitation of this study was the small population
size, limited by ethic al considerations. As the study aimed to
evaluate the feasibility of a technique, it is evident that the study
population is small and can’t represent the general population.
Additionally, the dogs were considered to be healthy based
on a physical exam and blood examination. Possible cardiac
diseases, such as systolic or diastolic dysfunction secondary to
intermittent arrhythmias, progressed myocarditis or primary
cardiomyopathies, could not be confidently ruled out without
an echocardiogram. Additionally, the DCE-CMR dataset could
be influenced by lack of reproducibility (i.e., between-day
variability) and repeatability (i.e., within-day variability), as this
could not have taken into consideration in the study design
due to ethical considerations. Although this is a limitation
of the study, this variability reflects the all-day-situation of
future examinations of clinical patients. A randomization of the
administration of the two doses, could have been a potential
improvement of the study to ensure that there was no carried
over effect between the stress measurements. Based on the
known short half-life time of adenosine (<10 s in human
plasma) and a break of several minutes between both stress
examinations, the influence of a potential carried over effect
should be negligible. As the aim of the study was to evaluate
the feasibility of a new technique in dogs, an interobserver
variability was not included, but could be of interest in further
studies.
In conclusion, this study showed that rest and stress
myocardial perfusion can be assessed using DCE-CMR in dogs
using the methods described. Our results indicated that both
adenosine dose and slice may affect semi-quantitative perfusion
data. Further studies are necessary to evaluate the usefulness
of DCE-CMR in the characterization of canine myocardial
disorders.
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